{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:57:28Z","timestamp":1761897448234,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.reuma.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T19:57:55Z","timestamp":1616270275000},"page":"331-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Caracter\u00edsticas de pacientes con enfermedades inflamatorias inmunomediadas hospitalizados por infecci\u00f3n por SARS-CoV-2"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5193-2500","authenticated-orcid":false,"given":"Montserrat","family":"Robustillo-Villarino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3745-4263","authenticated-orcid":false,"given":"Laura","family":"\u00c1lvarez-Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4459-6059","authenticated-orcid":false,"given":"Francisco Javier","family":"Carrera-Hueso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6129-639X","authenticated-orcid":false,"given":"In\u00e9s","family":"Barreda-Altaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3968-510X","authenticated-orcid":false,"given":"Mar\u00eda","family":"Nieto-Cid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0669-4587","authenticated-orcid":false,"given":"Ana Mar\u00eda","family":"Girona-Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4837-782X","authenticated-orcid":false,"given":"David","family":"El-Qutob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2021.03.003_bib0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jbspin.2020.03.010","article-title":"Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases","volume":"87","author":"Richez","year":"2020","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.reuma.2021.03.003_bib0150","doi-asserted-by":"crossref","first-page":"102523","DOI":"10.1016\/j.autrev.2020.102523","article-title":"COVID-19 infection and rheumatoid arthritis: Faraway, so close!","volume":"19","author":"Favalli","year":"2020","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.reuma.2021.03.003_bib0155","doi-asserted-by":"crossref","first-page":"104361","DOI":"10.1016\/j.jcv.2020.104361","article-title":"The clinical course and its correlated immune status in COVID-19 pneumonia","volume":"127","author":"He","year":"2020","journal-title":"J Clin Virol."},{"key":"10.1016\/j.reuma.2021.03.003_bib0160","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.reuma.2021.03.003_bib0165","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.medmal.2020.04.002","article-title":"Interleukin-6 as a potential biomarker of COVID-19 progression","volume":"50","author":"Ulhaq","year":"2020","journal-title":"Med Mal Infect."},{"key":"10.1016\/j.reuma.2021.03.003_bib0170","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.reuma.2021.03.003_bib0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMc2009567","article-title":"Covid-19 in immune-mediated inflammatory diseases \u2014 case series from New York","volume":"383","author":"Haberman","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.reuma.2021.03.003_bib0180","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/annrheumdis-2020-217948","article-title":"Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies","volume":"79","author":"Sanchez-Piedra","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2021.03.003_bib0185","doi-asserted-by":"crossref","first-page":"102502","DOI":"10.1016\/j.jaut.2020.102502","article-title":"SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients","volume":"112","author":"Zen","year":"2020","journal-title":"J Autoimmun."},{"key":"10.1016\/j.reuma.2021.03.003_bib0190","doi-asserted-by":"crossref","first-page":"102575","DOI":"10.1016\/j.autrev.2020.102575","article-title":"SARS-CoV-2 infection among patients with systemic autoimmune diseases","volume":"19","author":"Emmi","year":"2020","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.reuma.2021.03.003_bib0195","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.semarthrit.2020.05.001","article-title":"Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs","volume":"50","author":"Michelena","year":"2020","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.reuma.2021.03.003_bib0200","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2021.03.003_bib0205","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jbspin.2020.05.003","article-title":"Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy","volume":"87","author":"Quartuccio","year":"2020","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.reuma.2021.03.003_bib0210","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2020-217763","article-title":"Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases","volume":"79","author":"Pablos","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2021.03.003_bib0215","unstructured":"Centers for Disease Control and Prevention (CDC) [consultado 10 Jan 2021]. Disponible en: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/pregnancy-breastfeeding.html"},{"key":"10.1016\/j.reuma.2021.03.003_bib0220","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00296-020-04698-y","article-title":"Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases","volume":"40","author":"Boyadzhieva","year":"2020","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.reuma.2021.03.003_bib0225","unstructured":"European Centre for Disease Prevention and Control (ECDC) [consultado 10 Jan 2021]. Disponible en: https:\/\/www.ecdc.europa.eu\/en\/covid-19\/surveillance\/case-definition"},{"key":"10.1016\/j.reuma.2021.03.003_bib0230","unstructured":"Asociaci\u00f3n Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS) [consultado 10 Jan 2021]. Disponible en: https:\/\/www.aemps.gob.es\/la-aemps\/ultima-informacion-de-la-aemps-acerca-del-covid-19\/tratamientos-disponibles-para-el-manejo-de-la-infeccion-respiratoria-por-sars-cov-2\/"},{"key":"10.1016\/j.reuma.2021.03.003_bib0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40620-020-00881-3","article-title":"The impact of COVID-19 pandemic on patients with ANCA associated vasculitis","volume":"34","author":"Kant","year":"2021","journal-title":"J Nephrol."},{"key":"10.1016\/j.reuma.2021.03.003_bib0240","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","volume":"79","author":"Monti","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reuma.2021.03.003_bib0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13063-020-04999-4","article-title":"Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial","volume":"22","author":"Les Bujanda","year":"2021","journal-title":"Trials."},{"key":"10.1016\/j.reuma.2021.03.003_bib0250","first-page":"1","article-title":"Methylprednisolone in adults hospitalized with COVID-19 pneumonia?: An open-label randomized trial (GLUCOCOVID)","author":"Corral-Gudino","year":"2021","journal-title":"Wien Klin Wochenschr."},{"key":"10.1016\/j.reuma.2021.03.003_bib0255","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/M20-4207","article-title":"Hydroxychloroquine in nonhospitalized adults with early COVID-19: A randomized trial","volume":"173","author":"Skipper","year":"2020","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.reuma.2021.03.003_bib0260","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3899\/jrheum.091461","article-title":"Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities","volume":"85","author":"El-Gabalawy","year":"2010","journal-title":"J Rheumatol Suppl."},{"key":"10.1016\/j.reuma.2021.03.003_bib0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jmv.26237","article-title":"Obesity aggravates COVID-19: a systematic review and meta-analysis","volume":"93","author":"Yang","year":"2021","journal-title":"J Med Virol."},{"key":"10.1016\/j.reuma.2021.03.003_bib0270","unstructured":"Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER) [consultado 10 Jan 2021]. Disponible en: https:\/\/www.ser.es\/el-coronavirus-covid-19-y-los-pacientes-con-enfermedades-reumaticas\/"},{"key":"10.1016\/j.reuma.2021.03.003_bib0275","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.reuma.2020.06.011","article-title":"Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2\/COVID-19 infection. Colombian Association of Rheumatology","volume":"16","author":"Saldarriaga Rivera","year":"2020","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.reuma.2021.03.003_bib0280","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/art.41388","article-title":"Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?","volume":"72","author":"Favalli","year":"2020","journal-title":"Arthritis Rheumatol."}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X21000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X21000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:02:56Z","timestamp":1761663776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X21000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1699258X21000887"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2021.03.003","relation":{},"ISSN":["1699-258X"],"issn-type":[{"type":"print","value":"1699-258X"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caracter\u00edsticas de pacientes con enfermedades inflamatorias inmunomediadas hospitalizados por infecci\u00f3n por SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}